Equities

Anatara Lifesciences Ltd

ANR:ASX

Anatara Lifesciences Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.058
  • Today's Change0.00 / 0.00%
  • Shares traded131.32k
  • 1 Year change+107.14%
  • Beta1.1900
Data delayed at least 20 minutes, as of Nov 15 2024 04:32 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Friday, Anatara Lifesciences Ltd (ANR:ASX) closed at 0.058, -20.55% below its 52-week high of 0.073, set on Sep 26, 2024.
52-week range
Today
0.021Jan 30 20240.073Sep 26 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.061
High0.061
Low0.058
Bid0.041
Offer0.057
Previous close0.058
Average volume85.97k
Shares outstanding192.89m
Free float132.34m
P/E (TTM)--
Market cap11.19m AUD
EPS (TTM)-0.0098
AUD
Data delayed at least 20 minutes, as of Nov 15 2024 04:32 GMT.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.